Reprofiling a classical anthelmintic, pyrvinium pamoate, as an anti-cancer drug targeting mitochondrial respiration

Pyrvinium pamoate (PP) is an FDA-approved classical anthelmintic, but is now attracting particular attention as an anti-cancer drug after recent findings of its potent cytotoxicity against various cancer cell lines only during glucose starvation, as well as its anti-tumor activity against hypovascul...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishii, Isao, Harada, Yasuo, Kasahara, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2012
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462317/
https://www.ncbi.nlm.nih.gov/pubmed/23061049
http://dx.doi.org/10.3389/fonc.2012.00137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462317/
https://www.ncbi.nlm.nih.gov/pubmed/23061049
http://dx.doi.org/10.3389/fonc.2012.00137

Ejemplares similares